background image

Paid Clinical Trials Memphis

Discover 565 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Saruparib

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Germantown TN, Little Rock AR, Nashville TN, Springdale ARshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Melphalan Injection with Standard ChemotherapyRetinoblastoma

Recruiting
PHASE2

Sponsor:

Children's Oncology Group

Location:

Memphis TN, Birmingham AL, Saint Louis MO, Atlanta GAshow 13 more

Code:

NCT05504291

Conditions

Bilateral Retinoblastoma

Childhood Intraocular Retinoblastoma

Group D Retinoblastoma

Stage I Retinoblastoma

Unilateral Retinoblastoma

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Etoposide

Examination Under Anesthesia

Magnetic Resonance Imaging

Shunt vs. Stent

Recruiting

Sponsor:

Carelon Research

Location:

Memphis TN, Birmingham AL, Saint Louis MO, Atlanta GAshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

LP352

Recruiting
PHASE3

Sponsor:

Longboard Pharmaceuticals

Location:

Memphis TN, Little Rock AR, Atlanta GA, Gulf Breeze FLshow 26 more

Code:

NCT06660394

Conditions

Dravet Syndrome

Eligibility Criteria

Sex: All

Age: 2 - 65

Healthy Volunteers: Not accepted

Interventions

LP352

Placebo

Radiation Therapy with Atezolizumab

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Memphis TN, Southhaven MS, Collierville TN, Jonesboro ARshow 100 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

BIIB091 & DRF

Recruiting
PHASE2

Sponsor:

Biogen

Location:

Cordova TN, Nashville TN, Saint Louis MO, Kansas City KSshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

Talquetamab, Daratumumab, Pomalidomide

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Memphis TN, Little Rock AR, Jackson MS, Saint Louis MOshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

CVN424

Recruiting
PHASE3

Sponsor:

Cerevance

Location:

Memphis TN, Tulsa OK, Lexington KY, Kansas City KSshow 15 more

Code:

NCT06553027

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

CVN424 75 mg

CVN424 150 mg

Placebo

Methylation Biomarkers

Recruiting

Sponsor:

Cyted Health Inc

Location:

Cordova TN

Code:

NCT06803927

Conditions

Barrett Esophagus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Barrett's Esophagus Test (LDT)

M5049

Recruiting
PHASE2

Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Location:

Memphis TN, Indianapolis IN, Columbus OH, Grand Blanc MIshow 4 more

Code:

NCT05540327

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

M5049 low dose

M5049 medium dose

M5049 high dose

Placebo

M5049 very high dose